Determining Developmental and Clinical Markers Affecting Urinary Function of Children With Spinal Dysraphism
NCT ID: NCT05962086
Last Updated: 2023-07-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1500 participants
OBSERVATIONAL
2022-10-22
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Urinary Markers of Detrusor Overactivity in Spina Bifida Patients
NCT02852317
Self-esteem and Neuro-urological Follow-up in Patients With Spina Bifida or Spinal Cord Injury
NCT01606618
Assessment of Hypotonia in Children With Down Syndrome
NCT05131542
Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
NCT04489498
Incontinence and MRI Results in Children with Cerebral Palsy
NCT05060211
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asan Medical Center
OTHER
Severance Hospital
OTHER
Samsung Medical Center
OTHER
Keimyung University Dongsan Medical Center
OTHER
Pusan National University Yangsan Hospital
OTHER
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kwanjin Park
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kwanjin Park, MD/PHD
Role: STUDY_CHAIR
Seoul National University Hospital
Sang Woon Kim, MD/PHD
Role: PRINCIPAL_INVESTIGATOR
Severance Hospital
Sang Hoon Song, MD/PHD
Role: PRINCIPAL_INVESTIGATOR
Asan Medical Center
Minki Baek, MD/PHD
Role: PRINCIPAL_INVESTIGATOR
Samsung Medical Center
Jae Min Chung, MD/PHD
Role: PRINCIPAL_INVESTIGATOR
Pusan National University Yangsan Hospital
Ji Yong Ha, MD/PHD
Role: PRINCIPAL_INVESTIGATOR
Keimyung University Dongsan Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, South Korea
Keimyung University Dongsan Medical Center
Daegu, , South Korea
Asan Medical Center
Seoul, , South Korea
Samsung Medical Center
Seoul, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Yonsei University Severance Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2210-092-1369
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.